TVARDI THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.12M.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2014-09-30 was $0.00.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2014-06-30 was $0.00.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2014-03-31 was $56.25M.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $1.12M.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2019 was $136.50M, a 48.27% increase from fiscal 2018.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2018 was $92.06M, a 6.77% increase from fiscal 2017.
- TVARDI THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2017 was $86.22M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $1.12M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $1.12M 10-Q · filed 2024-11-14 | |
| 2019-12-31 | $136.50M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $92.06M 10-K · filed 2021-02-25 | |
| 2017-12-31 | $86.22M 10-K · filed 2020-02-27 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2014-03-31 | $56.25M 10-Q · filed 2015-05-12 | |
| 2012-12-31 | $86.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |